Retinoid receptor antagonists alter the pattern of apoptosis in organogenesis stage mouse limbs

Toxicological Sciences

Volumn 90, Issue 1, 2006, Pages 208-220

  Ali Khan, Sarah E ^a   Hales, Barbara F ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Limb development; Limb malformations; Retinoic acid; Teratogen

Indexed keywords

HETERODIMER; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; RETINOL;

ANALYSIS OF VARIANCE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EXPOSURE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENE SEQUENCE; IN VITRO STUDY; LIMB DEVELOPMENT; LIMB MALFORMATION; MALE; MORPHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ABNORMALITIES, DRUG-INDUCED; APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL DEVELOPMENT; LIMB BUD; LIMB DEFORMITIES, CONGENITAL; MICE; ORGANOGENESIS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; TERATOGENS; VITAMIN A;

ANIMALIA; MURINAE;

EID: 33144469119     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfj060     Document Type: Article

References (41)

1. Ahuja, H. S., James,W., and Zakeri, Z. (1997). Rescue of the limb deformity in hammertoe mutant mice by retinoic acid-induced cell death. Dev. Dyn. 208, 466-481.
2. Ali-Khan, S. E., and Hales, B. F. (2003). Caspase-3 mediates retinoid-induced apoptosis in the organogenesis-stage mouse limb. Birth Defects Res. A Clin. Mol. Teratol. 67, 848-860.
3. Alles, A. J., and Sulik, K. K. (1989). Retinoic-acid-induced limb-reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology 40, 163-171.
4. Arafa, H. M., Elmazar, M. M., Hamada, F. M., Reichert, U., Shroot, B., and Nau, H. (2000). Selective agonists of retinoic acid receptors: Comparative toxicokinetics and embryonic exposure. Arch. Toxicol. 73, 547-556.
5. Chambon, P. (1994). The retinoid signaling pathway: Molecular and genetic analyses. Semin. Cell Biol. 5, 115-125.
6. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. Faseb J. 10, 940-954.
7. Chen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., and Gronemeyer, H. (1995). RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14, 1187-1197.
8. Dolle, P., Ruberte, E., Leroy, P., Morriss-Kay, G., and Chambon, P. (1990). Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 110, 1133-1151.
9. Dupe, V., Ghyselinck, N. B., Thomazy, V., Nagy, L., Davies, P. J., Chambon, P., and Mark, M. (1999). Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208, 30-43.
10. Ebisawa, M., Umemiya, H., Ohta, K., Fukasawa, H., Kawachi, E., Christoffel, G., Gronemeyer, H., Tsuji, M., Hashimoto, Y., Shudo, K., et al. (1999). Retinoid X receptor-antagonistic diazepinylbenzoic acids. Chem. Pharm. Bull. (Tokyo) 47, 1778-1786.
11. Elmazar, M. M., Ruhl, R., and Nau, H. (2001). Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist. Toxicol. Appl. Pharmacol. 170, 2-9.
12. Francis-West, P., and Tickle, C. (1996). Limb development. Curr. Top. Microbiol. Immunol. 212, 239-259.
13. Horton, C., and Maden, M. (1995). Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo. Dev. Dyn. 202, 312-323.
14. Huang, C., and Hales, B. F. (2002). Role of caspases in murine limb bud cell death induced by 4-hydroperoxycyclophosphamide, an activated analog of cyclophosphamide. Teratology 66, 288-299.
15. Jiang, H., Penner, J. D., Beard, R. L., Chandraratna, R. A., and Kochhar, D. M. (1995). Diminished teratogenicity of retinoid X receptor-selective synthetic retinoids. Biochem. Pharmacol. 50, 669-676.
16. Kastner, P., Mark, M., Ghyselinck, N., Krezel, W., Dupe, V., Grondona, J. M., and Chambon, P. (1997). Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124, 313-326.
17. Kochhar, D. M. (1973). Limb development in mouse embryos. I. Analysis of teratogenic effects of retinoic acid. Teratology 7, 289-298.
18. Kochhar, D. M. (1985). Skeletal morphogenesis: Comparative effects of a mutant gene and a teratogen. Prog. Clin. Biol. Res. 171, 267-281.
19. Kochhar, D. M., Jiang, H., Penner, J. D., Beard, R. L., and ChandraratnaAs (1996). Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid. Chem. Biol. Interact. 100, 1-12.
20. Kwasigroch, T. E., Skalko, R. G., and Church, J. K. (1984). Mouse limb bud development in submerged culture: Quantitative assessment of the effects of in vivo exposure to retinoic acid. Teratog. Carcinog. Mutagen. 4, 311-326.
21. Leid, M., Kastner, P., and Chambon, P. (1992). Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17, 427-433.
22. Matt, N., Ghyselinck, N. B., Wendling, O., Chambon, P., and Mark, M. (2003). Retinoic acid-induced developmental defects are mediated by RARbeta/RXR heterodimers in the pharyngeal endoderm. Development 130, 2083-2093.
23. Mic, F. A., Molotkov, A., Benbrook, D. M., and Duester, G. (2003). Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc. Natl. Acad. Sci. U.S.A. 100, 7135-7140.
24. Mic, F. A., Sirbu, I. O., and Duester, G. (2004). Retinoic acid synthesis controlled by Raldh2 is required early for limb bud initiation and then later as a proximodistal signal during apical ectodermal ridge formation. J. Biol. Chem. 279, 26698-26706.
25. Minucci, S., Leid, M., Toyama, R., Saint-Jeannet, J. P., Peterson, V. J., Horn, V., Ishmael, J. E., Bhattacharyya, N., Dey, A., Dawid, I. B., et al. (1997). Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol. Cell. Biol. 17, 644-655.
26. Mirkes, P. E., and Little, S. A. (2000). Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol. Appl. Pharmacol. 162, 197-206.
27. Mollard, R., Viville, S., Ward, S. J., Decimo, D., Chambon, P., and Dolle, P. (2000). Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo. Mech. Dev. 94, 223-232.
28. Nagpal, S., Friant, S., Nakshatri, H., and Chambon, P. (1993). RARs and RXRs: Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J. 12, 2349-2360.
29. Niederreither, K., Vermot, J., Schuhbaur, B., Chambon, P., and Dolle, P. (2002). Embryonic retinoic acid synthesis is required for forelimb growth and anteroposterior patterning in the mouse. Development 129, 3563-3574.
30. Novack, D. V., and Korsmeyer, S. J. (1994). Bcl-2 protein expression during murine development. Am. J. Pathol. 145, 61-73.
31. Neubert, D. and Barrach, H.-J. (1977). Techniques applicable to study morphogenetic differentiation of limb buds in organ culture In Methods in pre-natal toxicology; evolution of embryotoxic effects in experimental animals. (D. Neubert, H.-J. Merker, T. Knaisgroch, Eds.), pp. 241-251. Georg Theme Pubs., Stuttgart, Germany.
32. Rossant, J., Zirngibl, R., Cado, D., Shago, M., and Giguere, V. (1991). Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev. 5, 1333-1344.
33. Sucov, H. M., Izpisua-Belmonte, J. C., Ganan, Y., and Evans, R. M. (1995). Mouse embryos lacking RXR alpha are resistant to retinoic-acid-induced limb defects. Development 121, 3997-4003.
34. Tzimas, G., Collins, M. D., Burgin, H., Hummler, H., and Nau, H. (1996). Embryotoxic doses of vitamin A to rabbits result in low plasma but high embryonic concentrations of all-trans-retinoic acid: Risk of vitamin A exposure in humans. J. Nutr. 126, 2159-2171.
35. Ulven, S. M., Gundersen, T. E., Weedon, M. S., Landaas, V. O., Sakhi, A. K., Fromm, S. H., Geronimo, B. A., Moskaug, J. O., and Blomhoff, R. (2000). Identification of endogenous retinoids, enzymes, binding proteins, and receptors during early postimplantation development in mouse: Important role of retinal dehydrogenase type 2 in synthesis of all-trans-retinoic acid. Dev. Biol. 220, 379-391.
36. Vivat, V., Zechel, C.,Wurtz, J. M., Bourguet,W., Kagechika, H., Umemiya, H., Shudo, K., Moras, D., Gronemeyer, H., and Chambon, P. (1997). A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J. 16, 5697-5709.
37. Weston, A. D., Blumberg, B., and Underhill, T. M. (2003). Active repression by unliganded retinoid receptors in development: Less is sometimes more. J. Cell Biol. 161, 223-228.
38. White, J. A., Beckett-Jones, B., Guo, Y. D., Dilworth, F. J., Bonasoro, J., Jones, G., and Petkovich, M. (1997). cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J. Biol. Chem. 272, 18538-18541.
39. Yang, L., Munoz-Medellin, D., Kim, H. T., Ostrowski, J., Reczek, P., and Brown, P. H. (1999). Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression. Breast Cancer Res. Treat. 56, 277-291.
40. Zakeri, Z. F., and Ahuja, H. S. (1994). Apoptotic cell death in the limb and its relationship to pattern formation. Biochem. Cell Biol. 72, 603-613.
41. Zakeri, Z. F., and Ahuja, H. S. (1997). Cell death/apoptosis: Normal, chemically induced, and teratogenic effect. Mutat. Res. 396, 149-161.